Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CNMD | Common Stock | Options Exercise | $0 | +1.25K | +16.95% | $0.00 | 8.63K | Mar 1, 2022 | Direct | |
transaction | CNMD | Common Stock | Tax liability | -$57K | -394 | -4.57% | $144.55 | 8.23K | Mar 1, 2022 | Direct | |
transaction | CNMD | Common Stock | Options Exercise | $0 | +1.25K | +15.19% | $0.00 | 9.48K | Mar 1, 2022 | Direct | |
transaction | CNMD | Common Stock | Tax liability | -$53K | -367 | -3.87% | $144.55 | 9.11K | Mar 1, 2022 | Direct | |
transaction | CNMD | Common Stock | Options Exercise | $0 | +1.05K | +11.52% | $0.00 | 10.2K | Mar 1, 2022 | Direct | |
transaction | CNMD | Common Stock | Tax liability | -$44.7K | -309 | -3.04% | $144.55 | 9.86K | Mar 1, 2022 | Direct | |
transaction | CNMD | Common Stock | Options Exercise | $210K | +5K | +50.74% | $41.93 | 14.9K | Mar 2, 2022 | Direct | |
transaction | CNMD | Common Stock | Sale | -$728K | -5K | -33.66% | $145.50 | 9.86K | Mar 2, 2022 | Direct | |
transaction | CNMD | Common Stock | Options Exercise | $18.5K | +308 | +3.13% | $59.96 | 10.2K | Mar 2, 2022 | Direct | |
transaction | CNMD | Common Stock | Sale | -$44.8K | -308 | -3.03% | $145.50 | 9.86K | Mar 2, 2022 | Direct | |
transaction | CNMD | Common Stock | Options Exercise | $8.66K | +110 | +1.12% | $78.76 | 9.97K | Mar 2, 2022 | Direct | |
transaction | CNMD | Common Stock | Sale | -$16K | -110 | -1.1% | $145.50 | 9.86K | Mar 2, 2022 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CNMD | Rsus (restricted Stock Units) | Options Exercise | $0 | -1.25K | -50% | $0.00 | 1.25K | Mar 1, 2022 | Common Stock | 1.25K | $0.00 | Direct | F1 |
transaction | CNMD | Rsus (restricted Stock Units) | Options Exercise | $0 | -1.25K | -33.33% | $0.00 | 2.5K | Mar 1, 2022 | Common Stock | 1.25K | $0.00 | Direct | F1 |
transaction | CNMD | Rsus (restricted Stock Units) | Options Exercise | $0 | -1.05K | -25% | $0.00 | 3.15K | Mar 1, 2022 | Common Stock | 1.05K | $0.00 | Direct | F1 |
transaction | CNMD | Options To Purchase Common Stock | Options Exercise | $0 | -5K | -100% | $0.00* | 0 | Mar 2, 2022 | Common Stock | 5K | $41.93 | Direct | F2 |
transaction | CNMD | Options To Purchase Common Stock | Options Exercise | $0 | -308 | -2.85% | $0.00 | 10.5K | Mar 2, 2022 | Common Stock | 308 | $59.96 | Direct | F2 |
transaction | CNMD | Options To Purchase Common Stock | Options Exercise | $0 | -110 | -1.93% | $0.00 | 5.59K | Mar 2, 2022 | Common Stock | 110 | $78.76 | Direct | F3 |
Id | Content |
---|---|
F1 | Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. |
F2 | The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. |
F3 | The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period |